POA Pharma, a reputable specialty pharmaceuticals partner owned by Galen Limited, has a strong presence in the industry.
In a landscape shaped by regulatory complexity and pricing pressures, POA Pharma is demonstrating that smart, regionally tailored growth can outperform scale.
Headquartered in Copenhagen and owned by Galen Limited, the company has steadily expanded its footprint across Northern Europe, earning a reputation as a trusted partner in specialty pharmaceuticals.
Galen Limited – founded in Craigavon, Northern Ireland in 1968 by the late Sir Allen McClay, a revered philanthropist and entrepreneur – built its strong commercial reputation in the UK and Ireland.
In 1997, Galen became Northern Ireland’s first £1 billion company and in 2002, Sir Allen formed what is now known as the Almac Group.
No direct quote available in the text.
Author's summary: POA Pharma expands across Northern Europe.